ClinicalTrials.gg
TerminatedNCT04676802Updated Oct 27, 2026

Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone

A Phase 4 interventional study of NSAID capsules and Opioid capsule in Pain, Postoperative and Osteoarthritis Thumb, sponsored by Stanford University. Terminated at 2 sites in United States. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Stanford University · Phase 4, Interventional, and Treatment

How we know

Why this study was terminated
Study drug supply unavailable
Updated Oct 27, 2026Now TerminatedPrimary completion moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
73
Allocation
Randomized
Ages
45 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative — 22 open to participants now, 25 under way, 3 of them phase 3. A drug class: Anti-Inflammatory Agents, Non-Steroidal · Pain, Postoperative.

Enrollment
140th of 229
73 · median 90
Started
2021
with 17 others
Phase 4
84 of 229
12 open now
Registered
160th of 229
by date

Among the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative, this one is the 140th largest by enrollment, is one of 18 that started in 2021, is one of 84 in phase 4, and was the 160th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

22 of the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative are open now, in 8 countries. Recruiting first, the newest first:

17 more — sign in →

By country, each count listing its studies:

All 22 open studies →

About Anti-Inflammatory Agents, Non-Steroidal

A class of medicines: which ones, and the studies of each, are on its page →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 45 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative, or all of them as a file.
02

Study summary

In the US, pain management after surgery for surgical treatment of osteoarthritis at the base of the thumb typically consists of prescription opioids during the early recovery phase. Given the highly addictive nature of prescription opioids, guidelines are being evaluated by hand surgeons to reduce opioid use while still maintaining pain control after surgery. A promising approach is to use non-narcotic medication as the first line of treatment. The purpose of this study is to demonstrate the efficacy of a combination of non-steroidal anti-inflammatory drugs (NSAIDs), ibuprofen and acetaminophen, in comparison to a morphine analogue substance (oxycodone) for pain management in the first 30 days after surgery.

03

Conditions studied

  • Pain, Postoperative
  • Osteoarthritis Thumb

Browse trials for

04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Undergoing trapeziectomy for thumb osteoarthritis

English proficient,

Exclusion criteria

Exclusion Criteria:

  • Pregnancy

Current use of opioids

Concurrent surgeries (ex. trapeziectomy combined with carpal tunnel release)

Inability to complete study forms (education, cognitive ability, mental status, medical status)

Allergy or intolerance to Ibuprofen, Acetaminophen and/or Oxycodone

Liver or kidney dysfunction, abnormal liver enzymes restricting use of acetaminophen or ibuprofen

History of chronic heart failure, upper gastrointestinal bleeding or coagulopathy

History of complex regional pain syndrome

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
73 participants (actual)

Study arms

  • Experimental
    NSAIDS

    Following surgery will receive NSAID capsules following surgery. Will take online and phone surveys.

    Drug: NSAID capsules

  • Experimental
    Opioids

    Following surgery will receive opioid capsules following surgery. Will take online and phone surveys.

    Drug: Opioid capsule

Interventions

06

What researchers measure

Primary outcomes

  1. Change of medication consumption and overall amount

    The number of capsules consumed in the last 24 hours. Consumption rate and overall consumption will be compared between groups to assess efficacy and inform further statistical analyses.

    Time frame: Every day from the first day after surgery to 30 days post-op.

  2. Change of worst daily pain score measured over time

    Numerical score describing surgical pain at its worst in the last 24 hours, between 1 and 10, 1 being no pain, 10 being the worst possible pain.

    Time frame: Every day from the first day after surgery to 30 days post-op.

  3. Change of least daily pain score measured over time

    Numerical score describing surgical pain at its least in the last 24 hours, between 1 and 10, 1 being no pain, 10 being the worst possible pain.

    Time frame: Every day from the first day after surgery to 30 days post-op.

  4. Change of average daily pain score measured over time

    Numerical score describing average surgical pain in the last 24 hours, between 1 and 10, 1 being no pain, 10 being the worst possible pain.

    Time frame: Every day from the first day after surgery to 30 days post-op.

Secondary outcomes

  1. Change in Quick DASH scores over time

    Quick Disabilities of the Arm, Shoulder, and Hand (qDASH) is a responsive measure to patient-reported functional change in the hand and upper extremity patient population, ranging from 0 to 100. Lower scores signify limited function and increased pain.

    Time frame: Baseline, Post-operative weeks 1, 3, 5, and 8

  2. Change in PROMIS-PI scores over time

    PROMIS-PI scores (Patient-Reported Outcomes Measurement Information System - Pain Interference) are effective measures of the change in perceived pain, supporting intervention related studies assessing power analyses for comparative research. We use the Pain Interference - Short Form version 6b, which consists of 6 questions regarding how much the pain experienced in the last 7 days interfered with everyday aspects of life (i.e. enjoyment, ability to concentrate, day to day activities, recreational activities, doing tasks away from home, and socializing with others). The answers to all questions are ordinals ranging from 1 (not interfered at all) to 5 (interfered very much).

    Time frame: Baseline, Post-operative weeks 1, 3, 5, and 8

07

Study locations

2 sites
  • Stanford Health Care
    Redwood City, California 94063, United States
  • University of Utah Health Care
    Salt Lake City, Utah 84112-, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Dec 2021 to primary completion in Jun 2026, 53 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 27, 2026: primary completion Feb 2027 → Jun 2026 and completion Aug 2027 → Jun 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 16, 2020
First posted
Dec 21, 2020
StartActual
Dec 27, 2021
Primary completionActual
Jun 18, 2026was Feb 2027
CompletionActual
Jun 18, 2026was Aug 2027
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Terminated Study drug supply unavailable
changed Oct 27, 2026
Primary completion
Feb 2027→Jun 18, 2026 (actual)
Oct 27, 2026
Study completion
Aug 2027→Jun 18, 2026 (actual)
Oct 27, 2026
Enrollment
121 (estimated)→73 (actual)
Oct 27, 2026
Design
Phase 2→Phase 4
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    Recruiting→Terminated
    Why stopped Study drug supply unavailable
    Primary completion Feb 2027→Jun 18, 2026 (now actual)
    Study completion Aug 2027→Jun 18, 2026 (now actual)
    Enrollment 121 (estimated)→73 (actual)
    Design Phase 2→Phase 4
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04676802
Responsible party
Amy Ladd (Professor of Orthopaedic Surgery, Stanford University) — Principal investigator
First posted
Dec 21, 2020
Start date
Dec 27, 2021
Primary completion
Jun 18, 2026
Completion
Jun 18, 2026
Last update
Oct 27, 2026

Study contacts

Amy Ladd, MD
principal investigator · Stanford Orthopaedic Surgery

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Anti-Inflammatory Agents, Non-Steroidal · Opioids

Start the discussion